242 related articles for article (PubMed ID: 26041661)
1. Efficient Docosahexaenoic Acid Uptake by the Brain from a Structured Phospholipid.
Hachem M; Géloën A; Van AL; Foumaux B; Fenart L; Gosselet F; Da Silva P; Breton G; Lagarde M; Picq M; Bernoud-Hubac N
Mol Neurobiol; 2016 Jul; 53(5):3205-3215. PubMed ID: 26041661
[TBL] [Abstract][Full Text] [Related]
2. Biological properties of a DHA-containing structured phospholipid (AceDoPC) to target the brain.
Lagarde M; Hachem M; Bernoud-Hubac N; Picq M; Véricel E; Guichardant M
Prostaglandins Leukot Essent Fatty Acids; 2015 Jan; 92():63-5. PubMed ID: 24582148
[TBL] [Abstract][Full Text] [Related]
3. Esterification of Docosahexaenoic Acid Enhances Its Transport to the Brain and Its Potential Therapeutic Use in Brain Diseases.
Lo Van A; Bernoud-Hubac N; Lagarde M
Nutrients; 2022 Oct; 14(21):. PubMed ID: 36364810
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Identification of AceDoxyPC, a Protectin-Containing Structured Phospholipid, Using Liquid Chromatography/Mass Spectrometry.
Lo Van A; Fourmaux B; Picq M; Guichardant M; Lagarde M; Bernoud-Hubac N
Lipids; 2017 Sep; 52(9):751-761. PubMed ID: 28776175
[TBL] [Abstract][Full Text] [Related]
5. Preferential incorporation of sn-2 lysoPC DHA over unesterified DHA in the young rat brain.
Thies F; Pillon C; Moliere P; Lagarde M; Lecerf J
Am J Physiol; 1994 Nov; 267(5 Pt 2):R1273-9. PubMed ID: 7977854
[TBL] [Abstract][Full Text] [Related]
6. Docosahexaenoic Acid (DHA) Bioavailability in Humans after Oral Intake of DHA-Containing Triacylglycerol or the Structured Phospholipid AceDoPC
Hachem M; Nacir H; Picq M; Belkouch M; Bernoud-Hubac N; Windust A; Meiller L; Sauvinet V; Feugier N; Lambert-Porcheron S; Laville M; Lagarde M
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31963708
[TBL] [Abstract][Full Text] [Related]
7. Targeting the Brain with a Neuroprotective Omega-3 Fatty Acid to Enhance Neurogenesis in Hypoxic Condition in Culture.
Lo Van A; Sakayori N; Hachem M; Belkouch M; Picq M; Fourmaux B; Lagarde M; Osumi N; Bernoud-Hubac N
Mol Neurobiol; 2019 Feb; 56(2):986-999. PubMed ID: 29858775
[TBL] [Abstract][Full Text] [Related]
8. Docosahexaenoic acid-containing choline phospholipid modulates LPS-induced neuroinflammation in vivo and in microglia in vitro.
Fourrier C; Remus-Borel J; Greenhalgh AD; Guichardant M; Bernoud-Hubac N; Lagarde M; Joffre C; Layé S
J Neuroinflammation; 2017 Aug; 14(1):170. PubMed ID: 28838312
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain.
Lagarde M; Bernoud N; Brossard N; Lemaitre-Delaunay D; Thiès F; Croset M; Lecerf J
J Mol Neurosci; 2001; 16(2-3):201-4; discussion 215-21. PubMed ID: 11478375
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of DHA transport to the brain and potential therapy to neurodegenerative diseases.
Lo Van A; Sakayori N; Hachem M; Belkouch M; Picq M; Lagarde M; Osumi N; Bernoud-Hubac N
Biochimie; 2016 Nov; 130():163-167. PubMed ID: 27496085
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of acetyl,docosahexaenoyl-glycerophosphocholine and its characterization using nuclear magnetic resonance.
Polette A; Deshayes C; Chantegrel B; Croset M; Armstrong JM; Lagarde M
Lipids; 1999 Dec; 34(12):1333-7. PubMed ID: 10652994
[TBL] [Abstract][Full Text] [Related]
12. Role of phosphatidylcholine-DHA in preventing APOE4-associated Alzheimer's disease.
Patrick RP
FASEB J; 2019 Feb; 33(2):1554-1564. PubMed ID: 30289748
[TBL] [Abstract][Full Text] [Related]
13. Fatty Acid-Binding Protein 5 Facilitates the Blood-Brain Barrier Transport of Docosahexaenoic Acid.
Pan Y; Scanlon MJ; Owada Y; Yamamoto Y; Porter CJ; Nicolazzo JA
Mol Pharm; 2015 Dec; 12(12):4375-85. PubMed ID: 26455443
[TBL] [Abstract][Full Text] [Related]
14. Brain targeting with docosahexaenoic acid as a prospective therapy for neurodegenerative diseases and its passage across blood brain barrier.
Hachem M; Belkouch M; Lo Van A; Picq M; Bernoud-Hubac N; Lagarde M
Biochimie; 2020 Mar; 170():203-211. PubMed ID: 32014503
[TBL] [Abstract][Full Text] [Related]
15. DHA metabolism: targeting the brain and lipoxygenation.
Picq M; Chen P; Perez M; Michaud M; Véricel E; Guichardant M; Lagarde M
Mol Neurobiol; 2010 Aug; 42(1):48-51. PubMed ID: 20422316
[TBL] [Abstract][Full Text] [Related]
16. Structured form of DHA prevents neurodegenerative disorders: A better insight into the pathophysiology and the mechanism of DHA transport to the brain.
Balakrishnan J; Kannan S; Govindasamy A
Nutr Res; 2021 Jan; 85():119-134. PubMed ID: 33482601
[TBL] [Abstract][Full Text] [Related]
17. Fatty Acid-Binding Protein 5 at the Blood-Brain Barrier Regulates Endogenous Brain Docosahexaenoic Acid Levels and Cognitive Function.
Pan Y; Short JL; Choy KH; Zeng AX; Marriott PJ; Owada Y; Scanlon MJ; Porter CJ; Nicolazzo JA
J Neurosci; 2016 Nov; 36(46):11755-11767. PubMed ID: 27852782
[TBL] [Abstract][Full Text] [Related]
18. A novel phosphatidylcholine which contains pentadecanoic acid at sn-1 and docosahexaenoic acid at sn-2 in Schizochytrium sp. F26-b.
Abe E; Hayashi Y; Hama Y; Hayashi M; Inagaki M; Ito M
J Biochem; 2006 Aug; 140(2):247-53. PubMed ID: 16829536
[TBL] [Abstract][Full Text] [Related]
19. Brain-targeting form of docosahexaenoic acid for experimental stroke treatment: MRI evaluation and anti-oxidant impact.
Chauveau F; Cho TH; Perez M; Guichardant M; Riou A; Aguettaz P; Picq M; Lagarde M; Berthezène Y; Nighoghossian N; Wiart M
Curr Neurovasc Res; 2011 May; 8(2):95-102. PubMed ID: 21443458
[TBL] [Abstract][Full Text] [Related]
20. Enrichment of brain docosahexaenoic acid (DHA) is highly dependent upon the molecular carrier of dietary DHA: lysophosphatidylcholine is more efficient than either phosphatidylcholine or triacylglycerol.
Sugasini D; Yalagala PCR; Goggin A; Tai LM; Subbaiah PV
J Nutr Biochem; 2019 Dec; 74():108231. PubMed ID: 31665653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
